痴呆症的司机:预测未来的未来
Mark Rapoport1,2, Patrick A Byrne3, Kim Pho3
1Department of Psychiatry, Termerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.
Journal of Alzheimer's disease : JAD
|June 4, 2025
概括
在安大略省,患有痴呆症的司机数量预计到2046年将增加200%以上. 这项研究预测痴呆症司机的数量将大幅增加,强调需要公共卫生和安全规划.
科学领域:
- 老年学是指老年学的学科.
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 驾驶技能下降是痴呆症患者的一个已知的问题.
- 需要准确的预测来规划未来的需求.
研究的目的:
- 估计和预测加拿大安大略省痴呆症司机的数量.
- 考虑痴呆症患者的性别差异和驾驶停止率.
主要方法:
- 利用了历史的省级许可证数据和人口预测.
- 纳入来自加拿大阿尔茨海默病协会的地标研究的痴呆症患病率估计.
- 对性别差异和停止驾驶的假设进行了敏感性分析.
主要成果:
- 预计到2046年,安大略省将有大约154,000名患有痴呆症的司机.
- 据估计,在过去二十年中,痴呆症的司机增加了221%至226%.
- 据模拟,女性停止驾驶的速度是男性的两倍.
结论:
- 痴呆症的患病率正在增加,导致痴呆症司机的预期激增.
- 强调需要加强对认知障碍驾驶员的健康和公共服务.
- 强调早期检测驾驶障碍和替代交通解决方案的重要性.
更多相关视频
11:12Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
17.5K
07:15Tactile Vibrating Toolkit and Driving Simulation Platform for Driving-Related Research
Published on: December 18, 2020
4.6K
相关概念视频
Dementia
182
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
182
Alzheimer's Disease: Overview
686
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
686
Alzheimer's Disease: Treatment
265
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
265
Current Trends in Nursing I
1.7K
Current trends in nursing include:
1.7K
